Brooke Private Equity Advisors
21
8M
19
0.95
0.10
10
- Stages of investment
- Areas of investment
Summary
In 2003 was created Brooke Private Equity Advisors, which is appeared as VC. The leading representative office of defined VC is situated in the Boston. The fund was located in North America if to be more exact in United States.
The top amount of exits for fund were in 2011. The fund is constantly included in less than 2 investment rounds annually. Opposing the other organizations, this Brooke Private Equity Advisors works on 4 percentage points more the average amount of lead investments. The usual things for fund are deals in the range of 5 - 10 millions dollars. The top activity for fund was in 2006.
The fund has no exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Clinipace, Anodyne Health, Sage Science. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 11-15 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Clinical Trials, Health Diagnostics.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Brooke Private Equity Advisors, startups are often financed by JMI Equity, Velocity Equity Partners, Hatteras Venture Partners. The meaningful sponsors for the fund in investment in the same round are JMI Equity, Velocity Venture Capital, Velocity Equity Partners. In the next rounds fund is usually obtained by Ascent Venture Partners, Velocity Equity Partners, MassVentures.
Investments analytics
Analytics
- Total investments
- 21
- Lead investments
- 0
- Exits
- 10
- Rounds per year
- 0.95
- Follow on index
- 0.10
- Investments by industry
- Health Care (10)
- Medical (5)
- Software (4)
- Enterprise Software (3)
- Manufacturing (3) Show 37 more
- Investments by region
-
- United States (21)
- Peak activity year
- 2006
- Number of Unicorns
- 2
- Number of Decacorns
- 2
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 18
- Avg. valuation at time of investment
- 163M
- Group Appearance index
- 0.57
- Avg. company exit year
- 19
- Avg. multiplicator
- 4.26
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| SWORD Health | 30 Jun 2021 | Therapeutic Devices, Other Healthcare Technology Systems, Health Care, Wellness, Medical, Personal Health, Therapeutics | Late Stage Venture | 85M | United States, New York, New York |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.